Showing results (241-250 of 301) with videos related to

Sort By:
Pageof 31
Cancer Medicine|September 2, 2022
Japanese subgroup analysis of EV-301: An open-label, randomized phase 3 study to evaluate enfortumab vedotin versus chemotherapy in subjects with previously treated locally advanced or metastatic urothelial carcinomaNobuaki Matsubara, Junji Yonese, Takahiro Kojima, et al.
European Urology|October 16, 2012
STAT3 polymorphism can predict the response to interferon-α therapy in patients with metastatic renal cell carcinomaMasatoshi Eto, Tomomi Kamba, Hideaki Miyake, et al.
Molecular Cancer Therapeutics|December 7, 2023
TAS0313 plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial CarcinomaHiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 24, 2002
In vivo gene transfer of hepatocyte growth factor to skeletal muscle prevents changes in rat kidneys after 5/6 nephrectomyToshiyuki Tanaka, Naotsugu Ichimaru, Shiro Takahara, et al.
International Journal of Clinical Oncology|October 29, 2024
Predicting time to castration resistance with androgen-receptor signaling inhibitors in hormone-sensitive prostate cancer: data from ULTRA-Japan ConsortiumTaizo Uchimoto, Kengo Iwatsuki, Kazumasa Komura, et al.
Aging Cell|January 26, 2021
Targeting age-specific changes in CD4+ T cell metabolism ameliorates alloimmune responses and prolongs graft survivalYeqi Nian, Jasper Iske, Ryoichi Maenosono, et al.
Transplantation Proceedings|June 28, 2025
Use of Preoperative Renal Volumetry to Predict Postdonation Renal Function With Inulin Clearance as Indicator in JapanAsuka Sano, Takayuki Sugiyama, Shinsuke Isobe, et al.
Clinical Genitourinary Cancer|January 31, 2026
Impact of Proton Pump Inhibitor Use on the Efficacy of IO-IO Versus IO-TKI Therapy in Metastatic Renal Cell CarcinomaLan Inoki, Shingo Toyoda, Wataru Fukuokaya, et al.
The Journal of Urology|December 21, 2010
Receptor heterodimerization: a new mechanism for platelet-derived growth factor induced resistance to anti-epidermal growth factor receptor therapy for bladder cancerPeter C Black, Gordon A Brown, Colin P Dinney, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|January 9, 2024
The medical cost and outcome of desensitization protocol in kidney transplantation recipients with high immunological risksRyoichi Maenosono, Kohei Unagami, Rikako Oki, et al.
Pageof 31